Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to his Department's press release of 14 May 2018 entitled Government announces £40 million for brain cancer research in honour of Tessa Jowell, what the planned timetable is for the roll-out of 5-AminoLevulinic Acid to all brain cancer centres in England.

The fluorescent dye 5-AminoLevulinic Acid (5-ALA) is already in use in some brain cancer centres. NHS England has communicated its commitment to implementation in all relevant National Health Service trusts and is currently working with neurosurgical centres to ensure that 5-ALA is available for use in accordance with National Institute for Health and Care Excellence guidelines from July 2018.